Free Trial
NYSEAMERICAN:IBIO

iBio (IBIO) Stock Price, News & Analysis

$0.74 +0.00 (+0.14%)
As of 07/3/2025 01:00 PM Eastern

About iBio Stock (NYSEAMERICAN:IBIO)

Key Stats

Today's Range
$0.72
$0.76
50-Day Range
$0.71
$1.06
52-Week Range
$0.64
$6.89
Volume
698,004 shs
Average Volume
1.60 million shs
Market Capitalization
$2.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

iBio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
2nd Percentile Overall Score

IBIO MarketRank™: 

iBio scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for iBio.

  • Percentage of Shares Shorted

    5.41% of the float of iBio has been sold short.
  • Short Interest Ratio / Days to Cover

    iBio has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iBio has recently increased by 30.64%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    iBio does not currently pay a dividend.

  • Dividend Growth

    iBio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.41% of the float of iBio has been sold short.
  • Short Interest Ratio / Days to Cover

    iBio has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iBio has recently increased by 30.64%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    3 people have searched for IBIO on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, iBio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.12% of the stock of iBio is held by insiders.

  • Percentage Held by Institutions

    Only 7.90% of the stock of iBio is held by institutions.

  • Read more about iBio's insider trading history.
Receive IBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iBio and its competitors with MarketBeat's FREE daily newsletter.

IBIO Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
iBio announces data from non-human primate PK study of IBIO-600
iBio to transfer listing to Nasdaq from NYSE
See More Headlines

IBIO Stock Analysis - Frequently Asked Questions

iBio's stock was trading at $2.42 at the beginning of 2025. Since then, IBIO stock has decreased by 69.4% and is now trading at $0.7410.

Shares of IBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iBio investors own include Mesoblast (MESO), Mobileye Global (MBLY), KULR Technology Group (KULR), IonQ (IONQ), Guardforce AI (GFAI), Fastly (FSLY) and Exscientia (EXAI).

Company Calendar

Today
7/05/2025
Next Earnings (Estimated)
9/19/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:IBIO
Employees
100
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$65.01 million
Pretax Margin
-41,546.00%

Debt

Sales & Book Value

Annual Sales
$2.38 million
Price / Cash Flow
N/A
Book Value
$15.15 per share
Price / Book
0.05

Miscellaneous

Free Float
3,445,000
Market Cap
$2.58 million
Optionable
N/A
Beta
-3.77
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSEAMERICAN:IBIO) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners